is semaglutide capitalized A $60 billion industry just found its next growth lever. 💊 With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs Omzo GLP-1 Review 2026: Is

Ethics declarations Conflict of interest All authors have no conflict of interest to declare

Research on patient preferences consistently shows overwhelming preference for nasal formulations, with feedback describing them as fastest and simplest. The elimination of needle-related anxiety, pain, and the need for sterile technique significantly reduces barriers to consistent therapy adherence

Nam gii b v sinh

Journal of the International Society of Sports Nutrition, 17 (1)

In plain terms: you feel full sooner, stay full longer, and think about food less

doi:10.1186/s12937-023-00908-y Zarshenas N, Tapsell LC, Batterham M, Neale EP, Talbot ML